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The thermodynamic equilibria of nickel(II) with N,N󸀠-di(aminoethylene)-2,6-pyridinedicarbonylamine (L1), Bis-(N,N-dimeth-
ylethyl)-2,6-pyridinedicarboxamide (L2), and N,N󸀠-bis[2(2-pyridyl)-methyl]pyridine-2,6-dicarboxamide (L3) have been studied
at 25∘C and an ionic strength of 0.15mol dm−3 by glass electrode potentiometry. The protonation and formation constants added
to blood plasma model predict that Cu(II) competes effectively against Ni(II), Zn(II), and Ca(II) for these ligands in vivo.
1. Introduction
Metal ions may be part of the active sites of enzymes, stabilise
themacromolecular structure of proteins, and affect enzymes
or membranes to control cell metabolism [1]. Nickel has long
been recognised as an essential constituent of the catalytic
center of four different types of enzymes, urease in plants,
hydrogenase, CO dehydrogenase, andmethyl CoM reductase
in some strains of bacteria [2]. Formany years, there has been
great interest in the study of complexes able to mimic active
sites of metalloproteins.
We have recently investigated the solution chemistry of
Cu2+, Zn2+, andCa2+ withN,N󸀠-di(aminoethylene)-2,6-pyri-
dinedicarbonylamine (L1), Bis-(N,N-dimethylethyl)-2,6-pyr-
idinedicarboxamide (L2), andN,N󸀠-bis[2(2-pyridyl)-methyl]
pyridine-2,6-dicarboxamide (L3) (Figure 1) for possible use
as copper-based anti-inflammatory drugs in the treatment of
rheumatoid arthritis [3, 4]. Zn2+ and Ca2+ were included in
the study as they are present in high concentration in vivo and
so are potential competitors of Cu2+. The potentiometric
results indicated that copper(II) formed stable complexes
with all these ligands. Blood plasma simulation studies
showed that L3 is better at mobilising Cu2+ than L1 and L2.
Biodistribution experiments on mice revealed that the cop-
per(II) complexes of these ligands have much longer biologi-
cal half-lives than those studied by Jackson et al. [5].
Although the concentration of free nickel(II) in blood
plasma is negligible [2], a high intake of nickel could
affect the concentration of the administration of copper(II)
antiarthritic agents. With this in mind, we have investigated
nickel(II) complexes of all these three ligand systems in
solution. Potentiometry was used to calculate formation con-
stants of these ligands with Ni2+ and blood plasmamodelling
was used to predict the ability of the metal to alter the
bioavailability of copper complexes previously investigated
[3, 4].
2. Experimental
The ligands L1, L2, and L3 were synthesised as described
previously [3, 4]. They were characterised spectroscopically
and by elemental analysis.
All solutions for potentiometry were prepared in glass
distilled water which had been boiled and cooled under
an inert atmosphere to remove dissolved carbon dioxide.
Recrystallized NaCl was used as background electrolyte at
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Figure 1: Schematic structures of ligands (L) studied.
an ionic strength of 0.15mol dm−3 (Cl−). Nickel(II) chloride,
HCl, NaOH, and EDTA (Merck) were commercially available
and of analytical grade.These were used without purification.
The 0.1mol dm−3 solutions of NaOH and HCl were prepared
from Merck Titrisol ampoules and standardized by titrating
with potassium hydrogen phthalate (KHP) and sodium
tetraborate decahydrate (Borax), respectively. The NaOH
solutions were further standardized against the standard HCl
solution. Acid-base titrationwas also used to check carbonate
contamination of the sodiumhydroxide titrant solution using
the Gran method [6]. The standardised solutions were used
within a short period of time after preparation and were
discarded whenever there were signs of carbonate contami-
nation.
The potentiometric titrations were performed under
an inert atmosphere of purified nitrogen, at 25∘C, using
Radiometer PHM 84 research pH meter and a Metrohm
Dosimat 665 piston burette, which were controlled by a
computer. The pH meter was equipped with a Metrohm
6.0222.100 glass electrode, its slope was determined from a
buffer line and the response intercept, E∘, was determined
in situ. Titrations were performed in the pH range 2–11
in the concentration range 3 × 10−4–1 × 10−3mol dm−3 at
metal ion to ligand ratios ranging between 1 : 1 and 1 : 3.
The data were analysed using the ESTA suite of computer
programs [7]. Various speciation models were tried based




-bar curves. The water
ionization constant (p𝐾
𝑤
) used was 13.73. The protonation
constants of the ligands and the overall formation constants of
the Ni(II) systems were computed using general expressions
given as follows:


















where 𝑝, 𝑞, and 𝑟 are stoichiometric coefficients of the
components in the complex.
Blood plasma modelling was performed using a blood
plasma equilibrium database consisting of 10 metal ions and
more than 5000 ligands [8]. To this database, the protonation
and Ni(II) formation constants determined in this study
were added. The database was used together with typical
constituent concentrations of blood plasma [8] to calculate
the speciation of the system and the plasma mobilizing
index (pmi) of the ligand. This was achieved using the
ECCLES (Evaluation of Constituent Concentration in Large
Equilibrium Systems) program [9]. Pmi is a measure of the
ability of a ligand to move metal ion from a protein bound
form to a low molecular weight form. It is defined by
pmi = (total concentration of low-molecular-weight
metal complex species in the presence of drug)
× (total concentration of low-molecular-weight
metal complex species in normal plasma)−1.
(3)
3. Results and Discussion
3.1. Potentiometry. The three measurable acid dissociation
(protonation) constants corresponding to the pyridyl nitro-
gens and terminal amino groups of L1, L2, and L3 are





) corresponds to the protonation of the terminal
amine or pyridyl nitrogen. The pK
𝑎
values of pyridine and
2-methylpyridine are reported as 5.34 and 6.14, respectively,
[10] whereas the introduction of a carbonyl group in 2-
methylpyridine resulted in a p𝐾
𝑎
value of 2.66 [11]. Thus,
a p𝐾
𝑎1
of 4.62 is reasonable for L3. Comparing L1 and L2,
one may expect the addition of two methyl groups in L2 to
increase p𝐾
𝑎1
through the methyl inductive effect. However,
in aqueous solution, the entropy of hydration outweighs the
inductive effect leading to the observed p𝐾
𝑎1
of L1 > p𝐾
𝑎1
of
L2 [12]. Since each ligand is symmetrical, one could expect







be the same as the first protonation constant, p𝐾
𝑎1
. However,
the second proton is added to a ligand that is already
protonated and so electronic repulsion makes addition of the
second protonmore difficult. In addition, there is an entropic
factor; for the first protonation step, there are two equivalent
sites available but, for the second protonation, there is only
one site, the other already being occupied. Jackson et al.
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Table 1: Formation constants (log𝛽
𝑝𝑞𝑟
) for Ni(II) complexes of








]/[M]𝑝[L]𝑞[H]𝑟, 𝐼 = 0.15mol dm−3
(NaCl), and 𝑇 = 25∘C.





L1 H+ 0 1 1 9.20 (0.01) 0.01 0.01
0 1 2 17.88 (0.01)
0 1 3 19.91 (0.03)
Ni(II) Model 1
1 1 1 13.88 (0.01) 0.02 0.01
1 1 −1 −1.82 (0.02)
1 1 −2 −10.92 (0.02)
Model 2
1 1 0 6.08 (0.04) 0.04 0.02
1 1 −1 −2.00 (0.04)
1 1 −2 −10.94 (0.04)
L2 H+ 0 1 1 8.64 (0.01) 0.01 0.01
0 1 2 16.72 (0.01)
0 1 3 18.46 (0.06)
Ni(II) Model 1
1 1 1 11.22 (0.07) 0.02 0.01
1 1 −1 −4.99 (0.02)
1 1 −2 −13.94 (0.01)
Model 2
1 1 0 2.17 (0.38) 0.02 0.01
1 1 −1 −5.05 (0.02)
1 1 −2 −13.99 (0.01)
L3 H+ 0 1 1 4.62 (0.01) 0.01 0.01
0 1 2 8.13 (0.01)
0 1 3 10.11 (0.05)
Ni(II) 1 1 1 7.70 (0.08) 0.03 0.02
1 1 0 3.69 (0.04)
1 1 −1 −2.65 (0.04)
1 1 −2 −9.84 (0.03)
𝜎
𝑝𝑞𝑟
denotes standard deviation in log𝛽
𝑝𝑞𝑟
, and 𝑅𝐻 and 𝑅𝐻lim are the




























= 9.31 and p𝐾
𝑎2
= 8.43) and N,N󸀠-

























) of 2.03, 1.74,
and 1.98 corresponding to the central pyridyl nitrogen for L1,
L2, and L3, respectively, is due to the electronic repulsion
effect and the base weakening effect of the adjacent amide
groups [13]. Therefore, it is expected that the protonation
constant corresponding to the central pyridyl nitrogen in L1,
L2, and L3 should decrease further when two amide groups
are present.
The complex formation (𝑍
𝑀
-bar) and the deprotonation
(𝑄
𝑀
-bar) functions [3, 4, 14, 15] derived from the experi-
mental data have been used to visualize the experimental
data and to decide on the speciation model. The 𝑍
𝑀
-bar
function measures the number of ligands bound per metal
ion while 𝑄
𝑀
-bar indicates the number of protons released
upon metal ion complexation. The two functions are derived
from the free and total concentrations of the participating
components as well as the protonation constants of the
ligands. The classical complex formation function should
level at a 𝑍
𝑀
-bar value of 1 for mononuclear ML species
formation. However, deviations from ideal behaviour are
indicative of the different speciation occurring in solution.
Figure 2(a) shows the 𝑍
𝑀
-bar function plotted against pL
(− log[L]) for Ni(II)-L1. The 𝑍
𝑀
-bars do not level off at 1
indicating that ML is not the only species in solution. The
splitting of the curves for different metal to ligand ratios is
due to the presence of polynuclear or protonated species,
while the fanning back of the curves is indicative of hydroxo-
and/or mixed hydroxospecies formation. The same pattern




-bar function (Figure 2(b)) rises at pH 4.5, the
start of complexation, and rises from0 to about 2.7 (n-bar> 2)
indicating that, approximately, three protons have been
released due to complexation. The n-bar function measures
the average number of protons that would be bound to the
ligand in the absence of the metal ion. The release of a fourth
proton is observed at pH > 9 and this was also found for the
L2 system. Early metal assisted deprotonation of the amide






The potentiometric data analysis using ESTA suite of






as shown in Table 1. This posed difficulty in deciding on the
model which best describes the system. Both models had low
standard deviation and Hamiltonian 𝑅-factors and described
the experimental data equally well as far as statistical criteria
were concerned and also on chemical grounds. However, the
model with MLH is favoured because of the splitting of the
𝑍
𝑀
-bar curves at low pH values, Figure 2(a). Without the
MLH species, the curves should be superimposable at low
pH. For L2, the high standard deviation (0.38) for 𝛽
110
also
supports selection of model 1. The reproducibility of repeat
titrations, low standard deviations, and the Hamilton 𝑅-
factors as well as an excellent agreement between the theoret-
ical and experimental complex formation and deprotonation
functions lends confidence to the results for these systems.





complexes of the Ni(II)-L systems are
given in Table 1. These values are lower than the corre-
sponding values for the Cu (II)-L1, Cu(II)-L2, and Cu(II)-
L3 systems [3, 4]. Zn(II) and Ca(II) were also found to
form reasonably stable complexes with these systems but
their stabilities are lower than that of Ni(II). The order of
stability Cu(II) > Ni(II) > Zn(II) > Ca(II) is as expected
[16]. Although Ni(II) is a weaker acid than Cu(II), high
intake of this essential metal ion could potentially disrupt or
alter the bioavailability of copper complexes administered as
antiarthritic agents. The speciation distribution curves given
in Figure 3(a) show a mixture of species at a physiological
pH of 7.4 for L1 and this was also observed for L2 whereas
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Figure 2: Experimental and theoretical (solid line) (a) formation
function and (b) deprotonation function curves for Ni(II)-L1 system
at 25∘C and an ionic strength 0.15M (Cl−1). M : L ratios 1 : 1 (◻), 1 : 2
(◊), and 1 : 3 (Δ) are displayed. The theoretical line was calculated
using model 1 given in Table 1.
L3 showed MLH
−2
as the predominant species at this pH
as shown in Figure 3(b). The reason for this, we believe, is
the preformed structure of L3 which facilitates metal assisted
deprotonation of the amide.
From potentiometric data given in Table 1, we have pro-
posed possible structures for the different species in solution,
Figure 4. The ligands in this study are based on the pyridine-
2,6-dicarboxamide moiety to which have been added two
ethylene linkages. Once deprotonated, the pyridine-2,6-
dicarboxamide unit should be planar and maintain planarity
in variousmetal complexes [17–19].The basal plane is defined
by the Namido-Npy-Namido coordination of the ligand. The
central pyridine nitrogen acts as an anchor for amide coor-
dination and it is also the first one to be coordinated to the
metal, thus allowing themetal to be in close proximity for the
amide ionization. Two possibilities for the MLH species are
shown in Figures 4(a) and 4(b). Between the two structures,
Figure (a) seems the more likely coordination geometry
because Figure (b) would be destabilised by the rigidity of
the pyridine moiety when both carbonyl oxygens are coor-
dinated. It is expected that as the pH increases, there would







































Figure 3: (a) Calculated speciation distribution graphs for a Ni(II)-
L1 solution ([M] = 0.00051mol dm−3 and [L] = 0.00101mol dm−3)
as a function of pH. (b) Calculated speciation distribution graphs
for a Ni(II)-L3 solution ([M] = 0.00051mol dm−3 and [L] =
0.00101mol dm−3) as a function of pH.
would induce ionization of the amide protons. From the four
proposed structures of ML, Figures 4(c)–4(f), Figure 4(f)
is favoured because of the two 5-membered chelate rings
that are formed. As for MLH
−1
, structure Figure 4(g) is
preferred over Figures 4(h) and 4(i). Brooker et al. have inves-
tigated 2,6-bis(1-propanecarboxamido-3-amino)pyridine (a
five nitrogen donor ligand) which is analogous to ligands in
our study [20, 21]. In the solid state, Ni(II) had a square planar
geometry with four coordinated nitrogen donor atoms. The
fifth nitrogen from the terminal amino groups was unco-
ordinated and protonated. We propose a similar geometry
for the MLH
−2
species of L1-3 with one uncoordinated
terminal amino/pyridine group, Figure 4(j). In the solid state,
Ni(II)-L3 system has been reported to form a trinuclear
complex as the major species and a monomeric complex
with four nitrogen donor coordination arrangements and
uncoordinated terminal pyridine group as the minor species
[17, 22].




















































































for L3; R = CH3 for L2; R = H for L1
Figure 4: Schematic representation of proposed structures of the various Nickel-ligand species.
3.2. Blood Plasma Simulation. In order to determine the in
vivo mobilization of Ni(II) by L1, L2, and L3, blood-plasma
modelling [8, 9] was used to estimate the ability of these
ligands to mobilize Ni(II). This was done by calculating
the plasma mobilizing index (pmi) of the ligand using a
thermodynamic model of blood plasma. The pmi of a metal
ion by a ligand is defined as the fractional increase in the
total concentration of low molecular mass (lmm) complexes
of the metal ion caused by the ligand.This takes into account
competition between the ligand and all the endogenous
metal ions and low molecular mass ligands present in the
blood plasma model. In calculating the pmi curves, use has
been made of the ECCLES model [3, 4] of blood plasma
to which formation constants determined in potentiometric
study have been added.
Inspection of Figure 5 shows that L3 is very poor at
mobilizing Ni(II) in blood plasma and in fact mobilizes
significantly more Cu(II), Ca(II), and Zn(II). A similar trend
was observed for L1 and L2. The selectivity factors are in the
order Cu(II)/Ca(II) > Cu(II)/Zn(II) > Cu(II)/ Ni(II) which is
in accordance with the Irving-Williams series [16].
The poor mobilization of Ni(II) by L1-3 is because the
ligands preferentially bind to Cu (II), Ca(II), and Zn(II). The
preferential binding to Cu(II) is understandable as Cu(II)
forms more stable complexes than Ni(II). However, Ni(II)
forms more stable complexes than Zn(II) and Ca(II). In vivo,


















Figure 5: Logarithms of Cu(II), Ni(II), Zn(II), and Ca(II) plasma
mobilizing index plotted against log[L3].
the free concentration of Ca(II) and Zn(II) is 1015 and 109
times greater than the free concentration of Ni(II) and this
higher concentration means that they are able to displace
Ni(II) from its complexes. At a total L3 concentration of
3.1mmol dm−3, the pmi for Ni(II) is very low (<0.1) which
means that the use of this ligand to mobilize Cu(II) as an
anti-inflammatory agent will not affect the speciation of the
essential metal ion, Ni(II). However, they will affect the
speciation of Ca(II) and Zn(II).
4. Conclusion
The ligands L1, L2, and L3 are quite selective towards Cu(II)
over Ni(II) due to the ease with which Cu(II) deprotonates
the amide nitrogen groups.The rigidity of the pyridyl moiety
and pyridyl nitrogen that acts as an anchor enhanced the
ionization of the amide protons in the presence of the Ni(II)
ion. Possible geometries for the different species in solution
were postulated based on a comparison with literature data.
The blood plasma simulation suggests that the speciation
of Ni(II) will not be adversely affected by the use of these
ligands as anti-inflammatory agents. However, the speciation
of Zn(II) and Ca(II) will be adversely affected.
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